Akèy › Myelom Miltip › Texas › Lubbock
Etid klinik pou Myelom Miltip nan Lubbock, TX
3 etid pou Myelom Miltip ap chèche patisipan nan sit nan ak bò kote Lubbock (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Ap rekriteFaz 3
- Joe Arrington Cancer Research Treatment Center, Lubbock
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 3
- Joe Arrington Cancer Research Treatment Center, Lubbock
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Ap rekriteFaz 3
- Joe Arrington Cancer Research and Treatment Center, Lubbock
Etid Myelom Miltip nan lòt vil
- New York City, NY60 etid
- Boston, MA42 etid
- Atlanta, GA41 etid
- Houston, TX38 etid
- Durham, NC37 etid
- Nashville, TN32 etid
- Denver, CO26 etid
- Columbus, OH24 etid
- Rochester, MN24 etid
- Baldwin Park, CA23 etid
- St. Louis, MO23 etid
- Washington, DC22 etid
Lòt etid nan Lubbock
- Maladi Crohn10 etid
- Kolit Ulseratif9 etid
- Kansè nan tete6 etid
- Kansè Poumon ki pa ti selil4 etid
- Atrit psoryatik3 etid
- Sipwa3 etid
- Obèsite3 etid
- Limfòm Burkitt3 etid
- Maladi Entestinal Anflamatwa3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.